» Articles » PMID: 14661926

Uptake of Chitosan and Associated Insulin in Caco-2 Cell Monolayers: a Comparison Between Chitosan Molecules and Chitosan Nanoparticles

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2003 Dec 10
PMID 14661926
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the uptake of chitosan molecules (fCS) and nanoparticles (fNP), and their ability to mediate insulin transport in Caco-2 cell monolayers.

Methods: Cell-associated fCS and fNP were evaluated by fluorometry, trypan blue quenching, and confocal microscopy using FITC-labeled chitosan. Chitosan-mediated transport of FITC-labeled insulin was studied in Caco-2 cell monolayers cultured on permeable inserts.

Results: Caco-2 cells showed twofold higher association with fNP than fCS after 2-h incubation with 1 mg/ml samples. fNP uptake was a saturable (Km 1.04 mg/ml; Vmax 74.15 microg/mg/h), concentration- and temperature-dependent process that was inhibited by coadministered chlorpromazine. fCS uptake was temperature dependent, but was less sensitive to concentration and was inhibited by filipin. Postuptake quenching with 100 microg/ml of trypan blue suggests a significant amount of intracellular fNP, although the bulk of fCS was extracellular. Internalized fNP were located by confocal microscopy at 15 microm from the apical membrane, but there was no apparent breaching of the basal membrane. This might explain the failure of the nanoparticles to mediate significant insulin transport across the Caco-2 cell monolayer.

Conclusions: Formulation of chitosan into nanoparticles transforms its extracellular interactions with the Caco-2 cells to one of cellular internalization via clathrin-mediated endocytosis.

Citing Articles

Site-Selective Approaches to Attain Fluorescent Human Insulin Conjugates: Balancing the Site of Labeling and the Activity.

Alkhawaja B, AlDabet G, Alkhawaja N, Ghanim B, Al-Khatib K, Reeksting S ACS Omega. 2025; 10(8):8140-8151.

PMID: 40060799 PMC: 11886657. DOI: 10.1021/acsomega.4c09498.


Ultrasonic Production of Chitosan Nanoparticles and Their Application Against Present in the Ataulfo Mango.

Solis Vizcaino I, Rubio Rosas E, Aguila Almanza E, Marin Castro M, Hernandez Cocoletzi H Polymers (Basel). 2024; 16(21).

PMID: 39518265 PMC: 11548500. DOI: 10.3390/polym16213058.


Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Kesharwani P, Halwai K, Jha S, Mughram M, Salman Almujri S, Almalki W Mol Cancer. 2024; 23(1):244.

PMID: 39482651 PMC: 11526716. DOI: 10.1186/s12943-024-02163-z.


Chitosan and nanoparticles insulate liver dysfunction in EAC-bearing mice.

Radwan A, Gebreel D, Allam S, El-Atrash A, Tousson E Toxicol Res (Camb). 2024; 13(2):tfae050.

PMID: 38559757 PMC: 10980792. DOI: 10.1093/toxres/tfae050.


Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin.

Liu M, Svirskis D, Proft T, Loh J, Huang Y, Wen J Pharmaceutics. 2024; 16(3).

PMID: 38543291 PMC: 10975061. DOI: 10.3390/pharmaceutics16030397.


References
1.
Artursson P, Karlsson J . Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991; 175(3):880-5. DOI: 10.1016/0006-291x(91)91647-u. View

2.
Thiele L, Rothen-Rutishauser B, Jilek S, Wunderli-Allenspach H, Merkle H, Walter E . Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?. J Control Release. 2001; 76(1-2):59-71. DOI: 10.1016/s0168-3659(01)00412-6. View

3.
Huang M, Ma Z, Khor E, Lim L . Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res. 2002; 19(10):1488-94. DOI: 10.1023/a:1020404615898. View

4.
Ma Z, Yeoh H, Lim L . Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci. 2002; 91(6):1396-404. DOI: 10.1002/jps.10149. View

5.
Hilgers A, Conradi R, Burton P . Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res. 1990; 7(9):902-10. DOI: 10.1023/a:1015937605100. View